Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion type Assertion NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_head.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion description "[(5) Vioxx also enhanced expression of COX-2, PPARy, Bax, and caspase-3, while inhibiting the expression of Bcl-2 and survivin, suggesting that COX-2 blockade might be useful in chemoprevention against gastric cancer possibly due to enhancement of the PPARy- and proapoptotic proteins-dependent apoptosis and the reduction in progastrin/gastrin-induced promotion of tumor growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion evidence source_evidence_literature NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion SIO_000772 14627349 NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion wasDerivedFrom befree-2016 NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.
- NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_assertion wasGeneratedBy ECO_0000203 NP421166.RAD7qrckbPONhFFuymb_g57OLSH4rcVujqFR8w7vHXwi0130_provenance.